Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 25 Jun 2026
No
Commercial Release (Import and Commercialization) Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.
EN
02 Sep 2021
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
- Decision on LMOs for direct use as food or feed, or for processing (Article 11, LMOs-FFP)
No
Yes
-
,Organization:Zoetis Indústria de Produtos Veterinários Ltda (Zoetis)
, BrazilPhone: 0800 011 1919,Fax:Email: adm-sac@zoetis.com,Website: https://www2.zoetis.com.br/,
Yes
Yes
Yes
- LMOs for processing
No
Approval of the import and/or use of the LMO(s) without conditions
Yes
Yes
Yes
Yes
-
BCH-LMO-SCBD-105260-1 Living Modified Organism VECTORMUNE® HVT-IBDCeva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-RA-BR-299521-1 Risk Assessment generated by a regulatory process Risk assessment Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.VECTORMUNE® HVT-IBD | Turkey herpesvirus, Meleagrid herpesvirus 1, Production of medical or pharmaceutical compounds (human or animal)
- Commercial release 7666-2021.pdf [ Portuguese ]